24HourWire
News from all angles
MedPage Today
Center
New AML Regimen for Unfit Patients Gets FDA's Blessing
(MedPage Today) -- The FDA on Wednesday approved a new all-oral regimen for newly diagnosed acute myeloid leukemia (AML) in patients ineligible for intensive chemotherapy. The combination of decitabi…